RAPT Therapeutics, Inc.

RAPTDelisted Mar 3, 2026

Industry: Pharmaceutical Preparations
SEC CIK: 0001673772

SEC filings (opens in a new tab)

RAPT Therapeutics, Inc. was delisted on Mar 3, 2026; its insiders filed their last Form 4 on Mar 5, 2026; 106 institutions reported holding it in 13F filings for Q4 2025, worth $1.02B in total; no superinvestor held it.

Q1 2023 vs. Q4 2022

How the institutions holding RAPT Therapeutics, Inc. changed between Q4 2022 and Q1 2023.

All holders in Q1 2023 All holders in Q4 2022

13F holders of RAPT: Q4 2022 compared with Q1 2023
Measure	Q4 2022	Of which not filed for Q1 2023	Q1 2023	Change
Holders	95	1	106	+12
Shares	32.1M	12.0K	33.3M	+1.25M (+3.9%)
Value	$634.7M	$238.0K	$610.5M	−$23.9M (−3.8%)

1 institution that held it in Q4 2022 haven't filed for Q1 2023 yet. Not filing isn't selling, so the changes leave them out.

New holders (27)

Institutions that held RAPT Therapeutics, Inc. at the end of Q1 2023 but not at the end of Q4 2022.

Institutions new to RAPT in Q1 2023
Institution	Shares	Value	% of portfolio
Cormorant Asset Management, LP	650,000	$11.9M	0.79%
Point72 Asset Management, L.P.	325,700	$5.98M	0.02%
Polar Asset Management Partners Inc.	315,900	$5.80M	0.10%
Boxer Capital, LLC	300,000	$5.50M	0.27%
Samlyn Capital, LLC	186,261	$3.42M	0.06%
Balyasny Asset Management LLC	101,264	$1.86M	0.01%
Qube Research & Technologies Ltd	99,609	$1.83M	0.01%
UBS Oconnor LLC	92,046	$1.69M	0.04%
Jefferies Financial Group Inc.	48,733	$894.3K	0.02%
Jane Street Group, LLC	44,458	$815.8K	0.00%
Wells Fargo & Company	38,947	$714.7K	0.00%
Jump Financial, LLC	33,710	$618.6K	0.03%
Gsa Capital Partners LLP	30,362	$557.0K	0.06%
Profund Advisors LLC	20,823	$382.1K	0.02%
Federated Hermes, Inc.	17,509	$321.3K	0.00%
Janus Henderson Group PLC	16,043	$294.3K	0.00%
Invesco Ltd.	15,124	$277.5K	0.00%
SG Americas Securities, LLC	13,058	$240.0K	0.00%
Axq Capital, LP	12,799	$234.9K	0.09%
Voya Investment Management LLC	10,958	$201.1K	0.00%
Cubist Systematic Strategies, LLC	7,827	$143.6K	0.00%
Belvedere Trading LLC	2,567	$47.1K	0.02%
Simplex Trading, LLC	1,916	$35.0K	0.00%
Tucker Asset Management LLC	979	$18.0K	0.01%
Ellevest, Inc.	30	$551	0.00%
Allworth Financial LP	20	$367	0.00%
CWM, LLC	22	$0	0.00%

Sold out (15)

Institutions that held RAPT Therapeutics, Inc. at the end of Q4 2022 and filed for Q1 2023 without it.

Institutions that sold out of RAPT in Q1 2023
Institution	Shares, Q4 2022	Value, Q4 2022
Braidwell LP	1,000,000	$19.8M
Schonfeld Strategic Advisors LLC	281,875	$5.58M
Woodline Partners LP	264,142	$5.23M
Logos Global Management LP	200,000	$3.96M
Ghost Tree Capital, LLC	125,000	$2.48M
Integral Health Asset Management, LLC	109,000	$2.16M
Cheyne Capital Management (UK) LLP	71,828	$1.42M
Regents of the University of California	34,926	$691.5K
Man Group plc	32,422	$642.0K
ExodusPoint Capital Management, LP	28,553	$565.0K
Weiss Multi-Strategy Advisers LLC	25,010	$495.0K
Pentwater Capital Management LP	25,000	$495.0K
Walleye Trading LLC	12,617	$249.8K
Mariner, LLC	10,474	$207.0K
Parallel Advisors, LLC	676	$13.4K

Not filed for Q1 2023 yet (1)

Institutions that held RAPT Therapeutics, Inc. at the end of Q4 2022 and haven't filed a 13F for Q1 2023. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding RAPT in Q4 2022 that haven't filed for Q1 2023
Institution	Shares, Q4 2022	Value, Q4 2022
Telemetry Investments, L.L.C.	12,000	$238.0K